Issue Information

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2024)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
di: Shibing Tao, et al.
Pubblicazione: (2024)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
di: Mathieu Blouin, et al.
Pubblicazione: (2024)

The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review
di: Hansa Mreyoud, et al.
Pubblicazione: (2024)

Comment on “The power and pitfalls of underpowered studies”
di: Chia Siang Kow, et al.
Pubblicazione: (2024)

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Yongyi Zhang, et al.
Pubblicazione: (2024)

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency
di: Zhiheng Yu, et al.
Pubblicazione: (2024)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
di: David B. Cluck, et al.
Pubblicazione: (2024)

Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries
di: Andrew D. Mosholder, et al.
Pubblicazione: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
di: Mohammed Aldhaeefi, et al.
Pubblicazione: (2024)

Warfarin dosage in a postpartum woman while breastfeeding: A case report
di: Ellen Uppuluri, et al.
Pubblicazione: (2024)

Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders
di: Emily E. Leppien, et al.
Pubblicazione: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
di: Elmar R. Alizadeh, et al.
Pubblicazione: (2024)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
di: Mennatullah Hasan, et al.
Pubblicazione: (2024)

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
di: C. Michael White, et al.
Pubblicazione: (2024)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
di: Candice L. Garwood, et al.
Pubblicazione: (2024)

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta‐analysis
di: Dongjun Xu, et al.
Pubblicazione: (2024)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
di: Lena Makortoff, et al.
Pubblicazione: (2024)